366 related articles for article (PubMed ID: 21472476)
1. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
Holtmann G; Bigard MA; Malfertheiner P; Pounder R
Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
[TBL] [Abstract][Full Text] [Related]
2. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
Boardman HF; Heeley G
Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
[TBL] [Abstract][Full Text] [Related]
3. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
[TBL] [Abstract][Full Text] [Related]
4. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
[TBL] [Abstract][Full Text] [Related]
5. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
Boardman HF; Delaney BC; Haag S
Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of OTC omeprazole].
Labenz J; Willmer C
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():110-4. PubMed ID: 23326929
[TBL] [Abstract][Full Text] [Related]
7. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
[TBL] [Abstract][Full Text] [Related]
8. Treatment of gastroesophageal reflux disease.
Pettit M
Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
[TBL] [Abstract][Full Text] [Related]
9. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?
Menees SB; Guentner A; Chey SW; Saad R; Chey WD
Am J Gastroenterol; 2015 Nov; 110(11):1516-25. PubMed ID: 26054623
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
Quartarone G
Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
[TBL] [Abstract][Full Text] [Related]
12. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists.
Mearin F; Ponce J; Ponce M; Balboa A; González MA; Zapardiel J
World J Gastroenterol; 2012 Sep; 18(35):4885-91. PubMed ID: 23002360
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.
Kierkus J; Oracz G; Korczowski B; Szymanska E; Wiernicka A; Woynarowski M
Drug Saf; 2014 May; 37(5):309-16. PubMed ID: 24706290
[TBL] [Abstract][Full Text] [Related]
15. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
[TBL] [Abstract][Full Text] [Related]
16. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
Simonson W
Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
Tjon JA; Pe M; Soscia J; Mahant S
Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
[TBL] [Abstract][Full Text] [Related]
19. PPI use in the OTC era: who to treat, with what, and for how long?
Inadomi JM; Fendrick AM
Clin Gastroenterol Hepatol; 2005 Mar; 3(3):208-15. PubMed ID: 15765438
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
